AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2017
Aug 8, 2017
30826_dirs_2017-08-08_51373e78-3864-4bfb-9a61-c46cf93eca85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2017-08-01
Reporting Person: EDDLEMAN ROY T (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $.01 par value | 4782344 | Direct |
Footnotes
F1: Includes 357,518 shares held for the reporting person's benefit in a 15-month escrow established in connection with the August 1, 2017 merger acquisition by Repligen Corporation of Spectrum, Inc.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23